Natixis Advisors LLC Has $33.61 Million Holdings in Aflac Incorporated (NYSE:AFL)

Natixis Advisors LLC grew its position in Aflac Incorporated (NYSE:AFL) by 7.3% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 300,630 shares of the financial services provider’s stock after purchasing an additional 20,402 shares during the quarter. Natixis Advisors LLC’s holdings in Aflac were worth $33,610,000 as of its most recent filing with the SEC.

Several other large investors also recently modified their holdings of the company. Y.D. More Investments Ltd acquired a new position in Aflac in the second quarter valued at $25,000. Covestor Ltd raised its position in shares of Aflac by 41.8% in the 3rd quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock worth $41,000 after acquiring an additional 107 shares in the last quarter. Kennebec Savings Bank acquired a new position in shares of Aflac in the 3rd quarter valued at about $45,000. Catalyst Capital Advisors LLC bought a new stake in shares of Aflac during the 3rd quarter valued at about $51,000. Finally, Fairscale Capital LLC acquired a new stake in Aflac during the second quarter worth approximately $54,000. 67.44% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the company. TD Cowen started coverage on Aflac in a report on Wednesday, October 9th. They set a “hold” rating and a $102.00 price target on the stock. Citigroup increased their target price on shares of Aflac from $84.00 to $93.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 23rd. Piper Sandler lifted their price target on shares of Aflac from $114.00 to $122.00 and gave the company an “overweight” rating in a research note on Wednesday, October 2nd. Bank of America increased their price objective on shares of Aflac from $115.00 to $124.00 and gave the stock a “buy” rating in a research report on Thursday, October 10th. Finally, UBS Group boosted their target price on Aflac from $84.00 to $109.00 and gave the company a “neutral” rating in a research report on Wednesday, August 14th. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, Aflac currently has an average rating of “Hold” and a consensus price target of $97.93.

Aflac Stock Performance

Shares of AFL opened at $111.32 on Monday. The stock has a 50-day moving average of $110.41 and a two-hundred day moving average of $99.70. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.08 and a current ratio of 0.08. The stock has a market cap of $61.84 billion, a P/E ratio of 16.77, a P/E/G ratio of 2.15 and a beta of 0.96. Aflac Incorporated has a one year low of $75.07 and a one year high of $115.50.

Aflac (NYSE:AFL) last posted its earnings results on Wednesday, October 30th. The financial services provider reported $2.16 EPS for the quarter, topping the consensus estimate of $1.69 by $0.47. Aflac had a return on equity of 16.34% and a net margin of 22.02%. The firm had revenue of $2.95 billion for the quarter, compared to analyst estimates of $4.30 billion. During the same period last year, the company earned $1.84 earnings per share. Aflac’s revenue for the quarter was down 40.4% compared to the same quarter last year. As a group, research analysts predict that Aflac Incorporated will post 7.22 EPS for the current year.

Aflac Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 2nd. Shareholders of record on Wednesday, November 20th will be issued a $0.50 dividend. The ex-dividend date of this dividend is Wednesday, November 20th. This represents a $2.00 dividend on an annualized basis and a yield of 1.80%. Aflac’s payout ratio is currently 30.12%.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.